Key Segments
By Product Type
-
Aneurysm Therapeutic Devices
-
Clips
-
Coils
-
Intravascular Devices
-
Flow Diverters
-
Embolization Devices
-
Occlusion Catheters
-
Embolic Agents
-
-
Aspiration Devices
-
Aspiration Catheters
-
Clot Retrieval Devices
-
-
Access Devices
-
Micro Catheters
-
Guidewires
-
By Aneurysm Type
-
Saccular Aneurysm
-
Fusiform Aneurysm
-
Mycotic Aneurysm
By Treatment Type
-
Surgical Clipping
-
Endovascular Coiling
-
Flow Diverters
-
Others (Bypass surgery, Stent-assisted coiling)
By End-User
-
Hospitals
-
Specialty Clinics
-
Others (Ambulatory Surgical Centers, Academic Institutes)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: Key players include Medtronic, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, MicroPort Scientific Corporation, and Penumbra, Inc., all of whom are focusing on R&D, FDA approvals, and global expansion.
Ans: North America holds the largest market share due to high procedure volumes and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, driven by increasing healthcare access, awareness, and investments.
Ans: Flow diverters are witnessing high adoption with a projected CAGR exceeding 10%, due to their effectiveness in treating complex and large aneurysms that are not suitable for coiling or clipping.
Ans: Endovascular coiling is the most widely adopted treatment, followed by flow diverters and surgical clipping, with endovascular approaches gaining dominance due to reduced invasiveness and faster recovery.
Ans: The market is driven by the rising incidence of unruptured aneurysms due to increased neuroimaging, growing preference for minimally invasive endovascular procedures, and technological advancements like flow diverters and embolization devices.